BGNE — Beigene ADR
Beigene
AI forecast: BGNE
There is no current AI forecast for this stock.
The AI publishes a target price for the next trading day, the end of the week and the end of the month. The change is measured from the latest price. These are statistical estimates, not investment advice.
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock PremiumAbout This Company
BeiGene, Ltd. is a commercial-stage biopharmaceutical company that specializes in the discovery, development, and commercialization of molecularly targeted and immuno-oncology therapies for the treatment of cancer. BeiGene serves patients worldwide.